Loading…
The Role of Helicobacter pylori in Patients with Hypothyroidism in Whom Could Not be Achieved Normal Thyrotropin Levels Despite Treatment with High Doses of Thyroxine
Background: Helicobacter pylori infection is a most frequent cause of chronic gastritis. H. pylori may decrease absorption of oral thyroxine by decreasing gastric acid secretion in the stomach. In this study, we aimed to investigate the change in thyroid function tests of the cases after H. pylori...
Saved in:
| Published in: | Helicobacter (Cambridge, Mass.) Mass.), 2011-04, Vol.16 (2), p.124-130 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c4370-7330f4a8492a46ecfdca305a27ad7813ade745039ca40615f63eb9f91f2aff5f3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c4370-7330f4a8492a46ecfdca305a27ad7813ade745039ca40615f63eb9f91f2aff5f3 |
| container_end_page | 130 |
| container_issue | 2 |
| container_start_page | 124 |
| container_title | Helicobacter (Cambridge, Mass.) |
| container_volume | 16 |
| creator | Bugdaci, Mehmet Sait Zuhur, Sayid Shafi Sokmen, Mehmet Toksoy, Buket Albayrak, Banu Altuntas, Yüksel |
| description | Background: Helicobacter pylori infection is a most frequent cause of chronic gastritis. H. pylori may decrease absorption of oral thyroxine by decreasing gastric acid secretion in the stomach. In this study, we aimed to investigate the change in thyroid function tests of the cases after H. pylori eradication who were not responding to high doses of thyroxine treatment before H. pylori eradication.
Methods: Hypothyroid cases who were not responding to high doses of thyroxine among the ones presented to Endocrinology and Gastroenterohepatology Clinics of Sisli Etfal Training and Research Hospital between 2009 and 2010 were included in the study. Thyroid function tests were performed two times in all cases before and after H. pylori eradication. Duodenal, antral and corporal biopsies, and jejunal aspirates and biopsies were taken during upper gastrointestinal system endoscopies performed in all patients. Cases without intestinal pathology were included in the study.
Results: Serum thyrotropin (TSH), free T3, and free T4 values before H. pylori eradication were 30.5 ± 28.8 IU/mL, 2.64 ± 0.56 pg/mL, and 0.92 ± 0.32 ng/mL, respectively, and after eradication were found to be 4.2 ± 10.6 IU/mL, 3.02 ± 0.61 pg/mL, and 1.3 ± 0.34 ng/mL, respectively (p values |
| doi_str_mv | 10.1111/j.1523-5378.2011.00830.x |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_872130454</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>872130454</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4370-7330f4a8492a46ecfdca305a27ad7813ade745039ca40615f63eb9f91f2aff5f3</originalsourceid><addsrcrecordid>eNqNkdFu0zAUhiMEYmPwCsh3XCXYsd04EjdTN1ZEVSZU1EvLTY6Ji1MH22XtC-0556ylt-Abn-Pz_f-x9GcZIrgg6XzcFISXNOe0EkWJCSkwFhQX-xfZ5XnwMtXpNWdU1BfZmxA2GGNOWf06uygJoxzX-DJ7XHaAvjsLyGk0A2sat1ZNBI-Gg3XeILNF9yoa2MaAHkzs0OwwuNgdvDOtCf04X3WuR1O3sy1auIjWgK6bzsAfGHvfK4uWIx-9GxI9TwMb0A2EwURASw8q9sn-5G5-dujGBQjjh551e7OFt9krrWyAd6f7Kvvx-XY5neXzb3dfptfzvGG0wnlFKdZMCVaXik2g0W2jKOaqrFRbCUJVCxXjmNaNYnhCuJ5QWNe6JrpUWnNNr7IPR9_Bu987CFH2JjRgrdqC2wUpqpJQzDj7N8lF2lgykUhxJBvvQvCg5eBNr_xBEizHOOVGjqnJMTU5ximf45T7JH1_WrJb99CehX_zS8CnI_BgLBz-21jObuepSPL8KDchwv4sV_6XnFS04nK1uJOL1WLKS3Evv9InKiy_dg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>858781248</pqid></control><display><type>article</type><title>The Role of Helicobacter pylori in Patients with Hypothyroidism in Whom Could Not be Achieved Normal Thyrotropin Levels Despite Treatment with High Doses of Thyroxine</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Bugdaci, Mehmet Sait ; Zuhur, Sayid Shafi ; Sokmen, Mehmet ; Toksoy, Buket ; Albayrak, Banu ; Altuntas, Yüksel</creator><creatorcontrib>Bugdaci, Mehmet Sait ; Zuhur, Sayid Shafi ; Sokmen, Mehmet ; Toksoy, Buket ; Albayrak, Banu ; Altuntas, Yüksel</creatorcontrib><description>Background: Helicobacter pylori infection is a most frequent cause of chronic gastritis. H. pylori may decrease absorption of oral thyroxine by decreasing gastric acid secretion in the stomach. In this study, we aimed to investigate the change in thyroid function tests of the cases after H. pylori eradication who were not responding to high doses of thyroxine treatment before H. pylori eradication.
Methods: Hypothyroid cases who were not responding to high doses of thyroxine among the ones presented to Endocrinology and Gastroenterohepatology Clinics of Sisli Etfal Training and Research Hospital between 2009 and 2010 were included in the study. Thyroid function tests were performed two times in all cases before and after H. pylori eradication. Duodenal, antral and corporal biopsies, and jejunal aspirates and biopsies were taken during upper gastrointestinal system endoscopies performed in all patients. Cases without intestinal pathology were included in the study.
Results: Serum thyrotropin (TSH), free T3, and free T4 values before H. pylori eradication were 30.5 ± 28.8 IU/mL, 2.64 ± 0.56 pg/mL, and 0.92 ± 0.32 ng/mL, respectively, and after eradication were found to be 4.2 ± 10.6 IU/mL, 3.02 ± 0.61 pg/mL, and 1.3 ± 0.34 ng/mL, respectively (p values <.001, .002, and <.001, respectively). After H. pylori eradication treatment, TSH decreased in all of the cases, factitious thyrotoxicosis developed in % 21 of these cases.
Conclusion: In hypothyroid cases, H. pylori gastritis may be responsible for an inadequate response to the treatment. H. pylori eradication in the cases receiving high doses of thyroxine has a risk for thyrotoxicosis.</description><identifier>ISSN: 1083-4389</identifier><identifier>EISSN: 1523-5378</identifier><identifier>DOI: 10.1111/j.1523-5378.2011.00830.x</identifier><identifier>PMID: 21435090</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Acid secretion ; Adult ; Amoxicillin - therapeutic use ; Clarithromycin - therapeutic use ; clinical trial ; Drug Therapy, Combination ; Female ; Gastritis - blood ; Gastritis - drug therapy ; Gastritis - microbiology ; Gastritis - physiopathology ; Helicobacter Infections - blood ; Helicobacter Infections - drug therapy ; Helicobacter Infections - physiopathology ; Helicobacter pylori ; Humans ; Hypothyroidism ; Hypothyroidism - blood ; Hypothyroidism - drug therapy ; Hypothyroidism - etiology ; Male ; Metronidazole - therapeutic use ; Middle Aged ; Tetracycline - therapeutic use ; Thyroid-stimulating hormone ; Thyrotropin - blood ; Thyroxine ; Thyroxine - blood ; Thyroxine - therapeutic use ; treatment failure ; Triiodothyronine - blood</subject><ispartof>Helicobacter (Cambridge, Mass.), 2011-04, Vol.16 (2), p.124-130</ispartof><rights>2011 Blackwell Publishing Ltd</rights><rights>2011 Blackwell Publishing Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4370-7330f4a8492a46ecfdca305a27ad7813ade745039ca40615f63eb9f91f2aff5f3</citedby><cites>FETCH-LOGICAL-c4370-7330f4a8492a46ecfdca305a27ad7813ade745039ca40615f63eb9f91f2aff5f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21435090$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bugdaci, Mehmet Sait</creatorcontrib><creatorcontrib>Zuhur, Sayid Shafi</creatorcontrib><creatorcontrib>Sokmen, Mehmet</creatorcontrib><creatorcontrib>Toksoy, Buket</creatorcontrib><creatorcontrib>Albayrak, Banu</creatorcontrib><creatorcontrib>Altuntas, Yüksel</creatorcontrib><title>The Role of Helicobacter pylori in Patients with Hypothyroidism in Whom Could Not be Achieved Normal Thyrotropin Levels Despite Treatment with High Doses of Thyroxine</title><title>Helicobacter (Cambridge, Mass.)</title><addtitle>Helicobacter</addtitle><description>Background: Helicobacter pylori infection is a most frequent cause of chronic gastritis. H. pylori may decrease absorption of oral thyroxine by decreasing gastric acid secretion in the stomach. In this study, we aimed to investigate the change in thyroid function tests of the cases after H. pylori eradication who were not responding to high doses of thyroxine treatment before H. pylori eradication.
Methods: Hypothyroid cases who were not responding to high doses of thyroxine among the ones presented to Endocrinology and Gastroenterohepatology Clinics of Sisli Etfal Training and Research Hospital between 2009 and 2010 were included in the study. Thyroid function tests were performed two times in all cases before and after H. pylori eradication. Duodenal, antral and corporal biopsies, and jejunal aspirates and biopsies were taken during upper gastrointestinal system endoscopies performed in all patients. Cases without intestinal pathology were included in the study.
Results: Serum thyrotropin (TSH), free T3, and free T4 values before H. pylori eradication were 30.5 ± 28.8 IU/mL, 2.64 ± 0.56 pg/mL, and 0.92 ± 0.32 ng/mL, respectively, and after eradication were found to be 4.2 ± 10.6 IU/mL, 3.02 ± 0.61 pg/mL, and 1.3 ± 0.34 ng/mL, respectively (p values <.001, .002, and <.001, respectively). After H. pylori eradication treatment, TSH decreased in all of the cases, factitious thyrotoxicosis developed in % 21 of these cases.
Conclusion: In hypothyroid cases, H. pylori gastritis may be responsible for an inadequate response to the treatment. H. pylori eradication in the cases receiving high doses of thyroxine has a risk for thyrotoxicosis.</description><subject>Acid secretion</subject><subject>Adult</subject><subject>Amoxicillin - therapeutic use</subject><subject>Clarithromycin - therapeutic use</subject><subject>clinical trial</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Gastritis - blood</subject><subject>Gastritis - drug therapy</subject><subject>Gastritis - microbiology</subject><subject>Gastritis - physiopathology</subject><subject>Helicobacter Infections - blood</subject><subject>Helicobacter Infections - drug therapy</subject><subject>Helicobacter Infections - physiopathology</subject><subject>Helicobacter pylori</subject><subject>Humans</subject><subject>Hypothyroidism</subject><subject>Hypothyroidism - blood</subject><subject>Hypothyroidism - drug therapy</subject><subject>Hypothyroidism - etiology</subject><subject>Male</subject><subject>Metronidazole - therapeutic use</subject><subject>Middle Aged</subject><subject>Tetracycline - therapeutic use</subject><subject>Thyroid-stimulating hormone</subject><subject>Thyrotropin - blood</subject><subject>Thyroxine</subject><subject>Thyroxine - blood</subject><subject>Thyroxine - therapeutic use</subject><subject>treatment failure</subject><subject>Triiodothyronine - blood</subject><issn>1083-4389</issn><issn>1523-5378</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqNkdFu0zAUhiMEYmPwCsh3XCXYsd04EjdTN1ZEVSZU1EvLTY6Ji1MH22XtC-0556ylt-Abn-Pz_f-x9GcZIrgg6XzcFISXNOe0EkWJCSkwFhQX-xfZ5XnwMtXpNWdU1BfZmxA2GGNOWf06uygJoxzX-DJ7XHaAvjsLyGk0A2sat1ZNBI-Gg3XeILNF9yoa2MaAHkzs0OwwuNgdvDOtCf04X3WuR1O3sy1auIjWgK6bzsAfGHvfK4uWIx-9GxI9TwMb0A2EwURASw8q9sn-5G5-dujGBQjjh551e7OFt9krrWyAd6f7Kvvx-XY5neXzb3dfptfzvGG0wnlFKdZMCVaXik2g0W2jKOaqrFRbCUJVCxXjmNaNYnhCuJ5QWNe6JrpUWnNNr7IPR9_Bu987CFH2JjRgrdqC2wUpqpJQzDj7N8lF2lgykUhxJBvvQvCg5eBNr_xBEizHOOVGjqnJMTU5ximf45T7JH1_WrJb99CehX_zS8CnI_BgLBz-21jObuepSPL8KDchwv4sV_6XnFS04nK1uJOL1WLKS3Evv9InKiy_dg</recordid><startdate>201104</startdate><enddate>201104</enddate><creator>Bugdaci, Mehmet Sait</creator><creator>Zuhur, Sayid Shafi</creator><creator>Sokmen, Mehmet</creator><creator>Toksoy, Buket</creator><creator>Albayrak, Banu</creator><creator>Altuntas, Yüksel</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>201104</creationdate><title>The Role of Helicobacter pylori in Patients with Hypothyroidism in Whom Could Not be Achieved Normal Thyrotropin Levels Despite Treatment with High Doses of Thyroxine</title><author>Bugdaci, Mehmet Sait ; Zuhur, Sayid Shafi ; Sokmen, Mehmet ; Toksoy, Buket ; Albayrak, Banu ; Altuntas, Yüksel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4370-7330f4a8492a46ecfdca305a27ad7813ade745039ca40615f63eb9f91f2aff5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acid secretion</topic><topic>Adult</topic><topic>Amoxicillin - therapeutic use</topic><topic>Clarithromycin - therapeutic use</topic><topic>clinical trial</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Gastritis - blood</topic><topic>Gastritis - drug therapy</topic><topic>Gastritis - microbiology</topic><topic>Gastritis - physiopathology</topic><topic>Helicobacter Infections - blood</topic><topic>Helicobacter Infections - drug therapy</topic><topic>Helicobacter Infections - physiopathology</topic><topic>Helicobacter pylori</topic><topic>Humans</topic><topic>Hypothyroidism</topic><topic>Hypothyroidism - blood</topic><topic>Hypothyroidism - drug therapy</topic><topic>Hypothyroidism - etiology</topic><topic>Male</topic><topic>Metronidazole - therapeutic use</topic><topic>Middle Aged</topic><topic>Tetracycline - therapeutic use</topic><topic>Thyroid-stimulating hormone</topic><topic>Thyrotropin - blood</topic><topic>Thyroxine</topic><topic>Thyroxine - blood</topic><topic>Thyroxine - therapeutic use</topic><topic>treatment failure</topic><topic>Triiodothyronine - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bugdaci, Mehmet Sait</creatorcontrib><creatorcontrib>Zuhur, Sayid Shafi</creatorcontrib><creatorcontrib>Sokmen, Mehmet</creatorcontrib><creatorcontrib>Toksoy, Buket</creatorcontrib><creatorcontrib>Albayrak, Banu</creatorcontrib><creatorcontrib>Altuntas, Yüksel</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Helicobacter (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bugdaci, Mehmet Sait</au><au>Zuhur, Sayid Shafi</au><au>Sokmen, Mehmet</au><au>Toksoy, Buket</au><au>Albayrak, Banu</au><au>Altuntas, Yüksel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Helicobacter pylori in Patients with Hypothyroidism in Whom Could Not be Achieved Normal Thyrotropin Levels Despite Treatment with High Doses of Thyroxine</atitle><jtitle>Helicobacter (Cambridge, Mass.)</jtitle><addtitle>Helicobacter</addtitle><date>2011-04</date><risdate>2011</risdate><volume>16</volume><issue>2</issue><spage>124</spage><epage>130</epage><pages>124-130</pages><issn>1083-4389</issn><eissn>1523-5378</eissn><abstract>Background: Helicobacter pylori infection is a most frequent cause of chronic gastritis. H. pylori may decrease absorption of oral thyroxine by decreasing gastric acid secretion in the stomach. In this study, we aimed to investigate the change in thyroid function tests of the cases after H. pylori eradication who were not responding to high doses of thyroxine treatment before H. pylori eradication.
Methods: Hypothyroid cases who were not responding to high doses of thyroxine among the ones presented to Endocrinology and Gastroenterohepatology Clinics of Sisli Etfal Training and Research Hospital between 2009 and 2010 were included in the study. Thyroid function tests were performed two times in all cases before and after H. pylori eradication. Duodenal, antral and corporal biopsies, and jejunal aspirates and biopsies were taken during upper gastrointestinal system endoscopies performed in all patients. Cases without intestinal pathology were included in the study.
Results: Serum thyrotropin (TSH), free T3, and free T4 values before H. pylori eradication were 30.5 ± 28.8 IU/mL, 2.64 ± 0.56 pg/mL, and 0.92 ± 0.32 ng/mL, respectively, and after eradication were found to be 4.2 ± 10.6 IU/mL, 3.02 ± 0.61 pg/mL, and 1.3 ± 0.34 ng/mL, respectively (p values <.001, .002, and <.001, respectively). After H. pylori eradication treatment, TSH decreased in all of the cases, factitious thyrotoxicosis developed in % 21 of these cases.
Conclusion: In hypothyroid cases, H. pylori gastritis may be responsible for an inadequate response to the treatment. H. pylori eradication in the cases receiving high doses of thyroxine has a risk for thyrotoxicosis.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21435090</pmid><doi>10.1111/j.1523-5378.2011.00830.x</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1083-4389 |
| ispartof | Helicobacter (Cambridge, Mass.), 2011-04, Vol.16 (2), p.124-130 |
| issn | 1083-4389 1523-5378 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_872130454 |
| source | Wiley-Blackwell Read & Publish Collection |
| subjects | Acid secretion Adult Amoxicillin - therapeutic use Clarithromycin - therapeutic use clinical trial Drug Therapy, Combination Female Gastritis - blood Gastritis - drug therapy Gastritis - microbiology Gastritis - physiopathology Helicobacter Infections - blood Helicobacter Infections - drug therapy Helicobacter Infections - physiopathology Helicobacter pylori Humans Hypothyroidism Hypothyroidism - blood Hypothyroidism - drug therapy Hypothyroidism - etiology Male Metronidazole - therapeutic use Middle Aged Tetracycline - therapeutic use Thyroid-stimulating hormone Thyrotropin - blood Thyroxine Thyroxine - blood Thyroxine - therapeutic use treatment failure Triiodothyronine - blood |
| title | The Role of Helicobacter pylori in Patients with Hypothyroidism in Whom Could Not be Achieved Normal Thyrotropin Levels Despite Treatment with High Doses of Thyroxine |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T02%3A12%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Helicobacter%20pylori%20in%20Patients%20with%20Hypothyroidism%20in%20Whom%20Could%20Not%20be%20Achieved%20Normal%20Thyrotropin%20Levels%20Despite%20Treatment%20with%20High%20Doses%20of%20Thyroxine&rft.jtitle=Helicobacter%20(Cambridge,%20Mass.)&rft.au=Bugdaci,%20Mehmet%20Sait&rft.date=2011-04&rft.volume=16&rft.issue=2&rft.spage=124&rft.epage=130&rft.pages=124-130&rft.issn=1083-4389&rft.eissn=1523-5378&rft_id=info:doi/10.1111/j.1523-5378.2011.00830.x&rft_dat=%3Cproquest_cross%3E872130454%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4370-7330f4a8492a46ecfdca305a27ad7813ade745039ca40615f63eb9f91f2aff5f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=858781248&rft_id=info:pmid/21435090&rfr_iscdi=true |